Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...

What they found was that anyone from between 20 to 39 should be able to swallow around 8.5 times in 30 seconds, those in their 40s should be able to swallow eight times, and those in their 50s should ...

It can be a friend, a very good friend." Margeson, an artist from Marietta, Georgia, is learning how a health care robot ...

NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced that two members of its ...

Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show g ...

Elon Musk's bold pursuit at Neuralink, the brain-chip technology firm he founded, is redefining the boundaries of human capability. Launching an ambitious global recruitment drive for patients to test ...

Learn more about whether Ionis Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Nine years later, at age 30, she became Boston’s first full-time female reporter in the male-dominated world of local television sports — a position that made her a familiar face on WBZ, embraced by ...

Cai Emmons, in the advanced stages of a degenerative disease, has just gotten off a Zoom call with a doctor to discuss end-of ...

Hirayama disease is a rare neurological disorder primarily affecting young males. This condition poses diagnostic challenges ...

Elon Musk’s Neuralink has taken its groundbreaking step into the future of technology. The company is issuing a global call for patients ...